Home › Funds › V. M. MANNING & CO., INC. › ABT

V. M. MANNING & CO., INC. position in ABT

ABBOTT LABORATORIES · Health Care

V. M. MANNING & CO., INC. reported holding 19,849 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$1.8M, representing 1.54% of its reported portfolio and ranking #11 among its reported holdings. V. M. MANNING & CO., INC. has disclosed ABT holdings in 3 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)19.85K sh
Reported value held$1.80M
Portfolio Weight1.54%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How V. M. MANNING & CO., INC.'s ABT position evolved

V. M. MANNING & CO., INC. first disclosed a stake in ABT in Q3 2025 at 20,508 shares (US$2.7M). Across 3 filings, V. M. MANNING & CO., INC. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 19,849 shares valued at US$1.8M — an increase of 990 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 20.51K $2.70M New
Q4 2025 18.86K $2.36M Reduce
Q2 2026 19.85K $1.80M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has V. M. MANNING & CO., INC. held ABT?

V. M. MANNING & CO., INC. has disclosed ABT holdings in 3 of the last 4 reported quarters, going back to Q3 2025.

What is V. M. MANNING & CO., INC.'s current position in ABT?

As of Q2 2026, V. M. MANNING & CO., INC. holds 19.85K shares of ABT (ABBOTT LABORATORIES), valued at $1.80M, representing 1.54% of its reported portfolio and ranking #11.

Has V. M. MANNING & CO., INC. been buying or selling ABT?

In the latest 13F filing (Q2 2026), V. M. MANNING & CO., INC. increased its position in ABT.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.